國軒高科(002074.SZ):子公司收到大眾汽車集團採購定點函
格隆匯5月10日丨國軒高科(002074.SZ)公佈,全資子公司合肥國軒高科動力能源有限公司近日收到Volkswagenwerk AG(大眾汽車集團)的採購定點函,公司將成為大眾汽車海外市場定點供應商供應大眾汽車磷酸鐵鋰“UnifiedCell(標準電芯)”動力鋰電池產品,這是公司繼取得大眾汽車中國市場三元和磷酸鐵鋰電芯的正式量產定點之後取得又一重大市場突破。該款電芯採用與中國市場相同的設計樣式和規格,面向大眾汽車集團全系列新能源汽車。相關產品的銷售價格將以市場公允價值進行定價,產品主要銷售和應用對象為海外市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.